DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

Rezultaty

ELPA will organize an event aimed at patients and the general public to increase awareness of patients and the general public for cirrhosis and related complications and potential new therapies

Go-online of the public project website

The DECISION website will go live with information on the project on the partners on the disease and it will offer public results for download and references to publications

First patient and layman event

ELPA will organize an event aimed at patients and the general public to increase awareness of patients and the general public for cirrhosis and related complications and potential new therapies

Public engagement strategy to design DECISION along with the need of patients

This document will define the DECISION public engagement strategy in an ethically and legally sound way and build the basis for D72

Codes of conduct applicable and research integrity policy including publications in journals

Definition of the DECISION Code of conduct and research integrity policy for research undertaken in DECISION and publication of results

Checklist for participants to assure informed consent / other mechanisms for those unable to give a written consent

Checklist for informed consent procedures for people unable to give written consent

First written draft of a model describing typical treatment paths in decompensated cirrhosis

Health economic model for treatment paths in decompensated cirrhosis

Project brochure and professional templates

The project flyer will give information on the project and contact details for distribution at conferences A professionally designed poster and PPt template will guarantee growing recognition of the project

Generation of rat models of acute decompensation of cirrhosis developing ACLF

Performing the described models of cirrhosis with the respective triggers of ACLF

Publikacje

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.

Autorzy: Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M.
Opublikowane w: J Hepatol., 2021, ISSN 1600-0641
Wydawca: Elsevier
DOI: 10.1016/j.jhep.2021.01.002

Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.

Autorzy: Chang J, Höfer P, Böhling N, et al.
Opublikowane w: JHEP Rep., 2022, ISSN 2589-5559
Wydawca: BMJ Journals
DOI: 10.1016/j.jhepr.2022.100442

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

Autorzy: Weiss E, de la Peña-Ramirez C, Aguilar F, et al.
Opublikowane w: Gut, 2023, ISSN 1468-3288
Wydawca: BMJ
DOI: 10.1136/gutjnl-2022-328708

Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure.

Autorzy: Zhang IW, Curto A, López-Vicario C, et al.
Opublikowane w: J Hepatol., 2022, ISSN 1600-0641
Wydawca: Elsevier
DOI: 10.1016/j.jhep.2021.08.009

Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis

Autorzy: Clària J, Curto A, Moreau R, et al.
Opublikowane w: J Hepatol., 2021, ISSN 1600-0641
Wydawca: Elsevier
DOI: 10.1016/j.jhep.2021.06.043

Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018).

Autorzy: Gu W, Hortlik H, Erasmus HP, et al.
Opublikowane w: Lancet Reg Health Eur., 2021, ISSN 2666-7762
Wydawca: Elsevier
DOI: 10.1016/j.lanepe.2021.100240

Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension

Autorzy: de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C;
Opublikowane w: J Hepatol., 2022, ISSN 1600-0641
Wydawca: Elsevier
DOI: 10.1016/j.jhep.2021.12.022

Leveraging omics to understand the molecular basis of acute-on-chronic liver failure

Autorzy: Joan Clària
Opublikowane w: instname:Universidad de Barcelona, Numer 1, 2021, ISSN 2628-491X
Wydawca: De Gruyter
DOI: 10.1515/almed-2021-0023

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.

Autorzy: Trebicka J, Gu W, de Ledinghen V, et al.
Opublikowane w: Gut, 2022, ISSN 1468-3288
Wydawca: BMJ
DOI: 10.1136/gutjnl-2020-323419

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study

Autorzy: Buch S, Innes H, Lutz PL, et al.
Opublikowane w: Gut, 2023, ISSN 1468-3288
Wydawca: BMJ Journals
DOI: 10.1136/gutjnl-2022-327196

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis

Autorzy: Innes H, Nischalke HD, Guha IN, et al.
Opublikowane w: Hepatol Commun., 2022, ISSN 2471-254X
Wydawca: Wolters Kluwer
DOI: 10.1002/hep4.1886

Essential role for albumin in preserving liver cells from TNFα-induced mitochondrial injury

Autorzy: Duran-Güell M, Garrabou G, Flores-Costa R, et al.
Opublikowane w: FASEB J, 2023, ISSN 1530-6860
Wydawca: Wiley
DOI: 10.1096/fj.202201526r

Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators.

Autorzy: Sánchez-Rodríguez MB, Téllez É, Casulleras M, et al.
Opublikowane w: Front Immunol., 2022, ISSN 1664-3224
Wydawca: Frontiers
DOI: 10.3389/fimmu.2022.842996

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).

Autorzy: Bischoff J, Gu W, Schwarze-Zander C, et al.
Opublikowane w: EClinicalMedicine., 2021, ISSN 2589-5370
Wydawca: Elsevier
DOI: 10.1016/j.eclinm.2021.101116

redicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures

Autorzy: Bissonnette J, Riescher-Tuczkiewicz A, Gigante E, et al.
Opublikowane w: J Thromb Haemost., 2022, ISSN 1538-7836
Wydawca: John Wiley
DOI: 10.1111/jth.15888

Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS

Autorzy: Li M, Li K, Tang S, et al.
Opublikowane w: JHEP Rep., 2022, ISSN 2589-5559
Wydawca: ELSEVIER
DOI: 10.1016/j.jhepr.2022.100448

Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure

Autorzy: Tao Lin, Shanshan Wang, Stefan Munker, Kyounghwa Jung, Ricardo U. Macías-Rodríguez, Astrid Ruiz-Margáin, Robert Schierwagen, Hui Liu, Chen Shao, Chunlei Fan, Rilu Feng, Xiaodong Yuan, Sai Wang, Franziska Wandrer, Christoph Meyer, Ralf Wimmer, Roman Liebe, Jens Kroll, Long Zhang, Tobias Schiergens, Peter ten Dijke, Andreas Teufel, Alexander Marx, Peter R. Mertens, Hua Wang, Matthias P.A. Ebert,
Opublikowane w: Hepatology, 2022, ISSN 0270-9139
Wydawca: John Wiley & Sons Inc.
DOI: 10.1002/hep.32119

Proresolving lipid mediators and liver disease.

Autorzy: Clària J, Flores-Costa R, Duran-Güell M, López-Vicario C.
Opublikowane w: Biochim Biophys Acta Mol Cell Biol Lipids., 2021, ISSN 1879-2618
Wydawca: Frontiers
DOI: 10.1016/j.bbalip.2021.159023

Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model.

Autorzy: Zhang S, Suen SC, Gong CL, et al.
Opublikowane w: JHEP Rep., 2021, ISSN 2589-5559
Wydawca: Elsevier
DOI: 10.1016/j.jhepr.2021.100367

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.

Autorzy: Reiniš J, Petrenko O, Simbrunner B, et al.
Opublikowane w: J Hepatol., 2023, ISSN 1600-0641
Wydawca: Elsevier
DOI: 10.1016/j.jhep.2022.09.012

Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis.

Autorzy: Tantai X, Liu Y, Yeo YH, et al.
Opublikowane w: J Hepatol., Numer Elsevier, 2022, Strona(/y) N/A, ISSN 1600-0641
Wydawca: Elsevier
DOI: 10.1016/j.jhep.2021.11.006

Albumin protects the liver from tumor necrosis factor α-induced immunopathology.

Autorzy: Duran-Güell, M, Flores-Costa, R, Casulleras, M, et al.
Opublikowane w: The FASEB Journal, 2021, ISSN 1530-6860
Wydawca: Wiley
DOI: 10.1096/fj.202001615rrr

Management of splanchnic vein thrombosis.

Autorzy: Elkrief L, Payancé A, Plessier A, et al.
Opublikowane w: JHEP Rep., 2023, ISSN 2589-5559
Wydawca: Elsevier
DOI: 10.1016/j.jhepr.2022.100667

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease.

Autorzy: López-Vicario C, Sebastián D, Casulleras M, et al.
Opublikowane w: Hepatology, 2023, ISSN 1527-3350
Wydawca: AALSD
DOI: 10.1002/hep.32647

Mitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts.

Autorzy: Zhang IW, López-Vicario C, Duran-Güell M, Clària J.
Opublikowane w: Front Mol Biosci., 2021, ISSN 2296-889X
Wydawca: Frontiers
DOI: 10.3389/fmolb.2021.772174

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments

Autorzy: Herath CB, Angus PW, Trebicka J.
Opublikowane w: Front Physiol., 2022, ISSN 1664-042X
Wydawca: Frontiers Research Foundation
DOI: 10.3389/fphys.2022.864083

Autorzy: Yu X, Elfimova N, Müller M, et al.
Opublikowane w: Cell Mol Gastroenterol Hepatol., 2022, ISSN 2352-345X
Wydawca: Elsevier Inc.
DOI: 10.1016/j.jcmgh.2022.02.013

Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models.

Autorzy: Johannes Chang; Jonathan Meinke; Moritz Geck; Marc Hebest; Nina Böhling; Ramona Dolscheid-Pommerich; Birgit Stoffel-Wagner; Glen Kristiansen; Marcus Overhaus; Leon O. Peyman; Sabine Klein; Frank E. Uschner; Maximilian J. Brol; Tim O. Vilz; Philipp Lingohr; Jörg C. Kalff; Christian Jansen; Christian P. Strassburg; Sven Wehner; Jonel Trebicka; Jonel Trebicka; Michael Praktiknjo
Opublikowane w: Frontiers in Physiology, Numer 1, 2021, ISSN 1664-042X
Wydawca: Frontiers Research Foundation
DOI: 10.3389/fphys.2021.720898

Acute-on-chronic liver failure: a global disease

Autorzy: Schulz M, Trebicka J.
Opublikowane w: Gut, 2021, ISSN 1468-3288
Wydawca: BMJ
DOI: 10.1136/gutjnl-2020-323973

Guidelines for reviewing health research and innovation that use emergent technologies and personal data

Autorzy: De Lecuona, I
Opublikowane w: 2020, ISBN 978-84-9168-646-0
Wydawca: Edicions de la Universitat de Barcelona

Rezultaty

Publikacje

Udostępnij tę stronę

Pobierz